Programme

The session will focus on research by EY analysing the accumulated experience of collaboration between pharmaceutical businesses and the government, as well as promising areas of this cooperation.

Moderator
Anna Guseva, Head of Transaction Advisory Services for Companies in Medical and Biological Industry in the CIS, EY

Speakers
Ilya Vesker, Director for Government Relations, Takeda Russia
Vadim Vlasov, President, Novartis Group of Companies in Russia; Regional Director for Eastern and Central Europe and CIS, Novartis
Mati Gill, Head of Government Affairs, Corporate Headquarters and Growth Markets, Teva Pharmaceutical Industries Ltd
Zakhar Golant, Chairman of the Board, Union of Pharmaceutical and Biomedical Clusters of Russia; Head of Healthcare Committee
Irina Panarina, General Manager, Russia and Eurasia, AstraZeneca
Sergey Tsyb, Deputy Minister of Industry and Trade of the Russian Federation

Vadim Vlasov

President, Novartis Group of Companies in Russia; Regional Director for Eastern and Central Europe and CIS, Novartis

Vadim Vlasov has been Country President of Novartis Group Russia since September 2010. In this role he is accountable for the local business operations management, interaction with external stakeholders, coordination of Novartis divisions and business units in Russia, the company reputation maintenance and development.
Prior to joining Novartis in 2003-2010 Mr. Vlasov occupied the position of Head of EADS/Airbus in Russia.
Previously, Mr. Vlasov served as Head of Siemens Medical Solutions and Country Manager of Acuson Corporation in Russia and CIS, worked in the Deputy Minister of Defense of the Russian Federation office.
Mr. Vlasov has a Degree of Mechanical Engineer (with honours) from Moscow Aviation Institute and completed Advanced Development Program at London and Harvard Business Schools.

Irina Panarina

General Manager, Russia and Eurasia, AstraZeneca

Since May 2017 Irina Panarina has been appointed to the position of General Manager of AstraZeneca, Russia and Eurasia. Irina is responsible for AstraZeneca business in Russia & Eurasia Area and she leads AstraZeneca Russia.
Irina Panarina has worked for AstraZeneca since 2009. In October 2015 Irina joined the Russian team as Cardiovascular and Metabolic Disease Business Unit Head. Before coming to Russia, Irina Panarina held the position of General Manager at AstraZeneca Ukraine.
Prior to joining AstraZeneca Irina held regional roles at GSK Pharma headquarters in London, UK.
Irina Panarina has work experience in marketing, product portfolio management, people development.
Irina Panarina has degrees from Newcastle University & South Bank University. She also holds MBA degree from INSEAD Business School.

Sergey Tsyb

Deputy Minister of Industry and Trade of the Russian Federation

Date of birth: 29 April 1968
Place of birth: Obninsk, Kaluga Region
Education: Graduated from G.V. Plekhanov Russian Academy of the Economics, PhD in Economics
Work history:
1991–2007: Executive positions in various businesses
2007–2008: Director, Chemical Technology Complex and Bio-Engineering Technology Department of the Ministry of Industry and Energy of the Russian Federation
2008–2013: Director, Chemical Technology Complex and Bio-Engineering Technology Department of the Ministry of Industry and Trade of the Russian Federation
Since 2013: Deputy Minister of Industry and Trade of the Russian Federation
Awards:
2009: Mercy honorary badge from the Ministry of Healthcare and Social Development of the Russian Federation
2011: Honorary Chemist title from the Ministry of Industry and Trade of the Russian Federation
2011: Prize of the Government of the Russian Federation in the field of science and technology for development and implementation of the scientific fundamentals of the national system of chemical product turnover safety
2015: Medal of the Service to the Motherland Order 2nd Degree
Civil rank: Full State Councillor of the Russian Federation, 1st Class